PIGNANI, Silvia
 Distribuzione geografica
Continente #
EU - Europa 2.183
NA - Nord America 1.008
AS - Asia 730
SA - Sud America 67
AF - Africa 17
OC - Oceania 2
Totale 4.007
Nazione #
FI - Finlandia 1.878
US - Stati Uniti d'America 972
SG - Singapore 265
CN - Cina 167
IT - Italia 89
VN - Vietnam 80
DE - Germania 74
HK - Hong Kong 58
BR - Brasile 46
TR - Turchia 30
FR - Francia 25
PL - Polonia 25
GB - Regno Unito 24
IN - India 23
JP - Giappone 23
CA - Canada 22
ID - Indonesia 20
UA - Ucraina 20
RU - Federazione Russa 13
MX - Messico 12
BD - Bangladesh 10
AR - Argentina 9
CO - Colombia 8
ES - Italia 8
SE - Svezia 8
MY - Malesia 6
ZA - Sudafrica 6
IR - Iran 5
KR - Corea 5
AE - Emirati Arabi Uniti 4
IQ - Iraq 4
KE - Kenya 4
NO - Norvegia 4
PK - Pakistan 4
SA - Arabia Saudita 4
LT - Lituania 3
MA - Marocco 3
UZ - Uzbekistan 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AT - Austria 2
AU - Australia 2
EC - Ecuador 2
GE - Georgia 2
IE - Irlanda 2
IL - Israele 2
KZ - Kazakistan 2
NP - Nepal 2
TN - Tunisia 2
AM - Armenia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MT - Malta 1
NL - Olanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
YE - Yemen 1
Totale 4.007
Città #
Helsinki 1.869
Singapore 162
Ashburn 108
San Jose 103
Santa Clara 69
Chandler 67
Beijing 49
Hong Kong 49
Fairfield 46
Ferrara 34
Munich 34
Dallas 31
New York 30
Izmir 29
Los Angeles 29
Woodbridge 29
Ho Chi Minh City 28
Houston 26
Warsaw 24
Nanjing 20
Ann Arbor 19
Council Bluffs 19
Hanoi 19
Wilmington 19
Seattle 18
Tokyo 18
Jacksonville 16
Shanghai 16
Jakarta 15
Princeton 14
Cambridge 13
Milan 12
Lauterbourg 11
São Paulo 10
Dearborn 8
Fairford 8
Montreal 8
Turku 8
Chennai 7
Medellín 7
Mexico City 7
Orem 7
Piemonte 7
Toronto 7
Atlanta 6
Bremen 6
Brooklyn 6
Chicago 6
Denver 6
Bologna 5
Buffalo 5
Changsha 5
Falkenstein 5
Frankfurt am Main 5
Hebei 5
Indore 5
Boston 4
Cagliari 4
Dammam 4
Guangzhou 4
Hangzhou 4
Kuala Lumpur 4
Moscow 4
Oslo 4
Paris 4
Phoenix 4
San Diego 4
Baghdad 3
Da Nang 3
Dhaka 3
Dong Ket 3
Falls Church 3
Ferrara di Monte Baldo 3
Jinan 3
Johannesburg 3
Krasnodar 3
London 3
Manchester 3
Nairobi 3
Ningbo 3
Ottawa 3
Querétaro 3
Redwood City 3
Rome 3
San Leandro 3
Tashkent 3
Acalanes Ridge 2
Alexandria 2
Almaty 2
Andover 2
Annapolis 2
Belvedere Spinello 2
Biên Hòa 2
Calcinato 2
Chapel Hill 2
Crema 2
Haiphong 2
Hải Dương 2
Kirkland 2
Kyiv 2
Totale 3.323
Nome #
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 2.041
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 284
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 226
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 208
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 182
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 174
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 162
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 157
Modulation at transcriptional and post-translational level to develop therapeutic approaches for coagulation factor deficiencies 152
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 138
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 126
Base and Prime editing of DNA as a new therapeutic option for Hemophilia A 112
New Genome Editing Approaches: Base And Prime Editing To Revert Hemophilia A-Causing Point Mutations 86
Totale 4.048
Categoria #
all - tutte 11.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 12 11 6
2021/2022106 7 14 1 3 6 5 1 1 5 7 5 51
2022/2023137 13 21 1 20 21 16 11 7 17 1 5 4
2023/202492 7 9 10 2 7 12 5 6 1 6 5 22
2024/2025432 9 20 30 17 54 63 11 3 78 27 64 56
2025/20262.842 93 32 75 144 169 68 124 93 1.946 98 0 0
Totale 4.048